Avantium NV operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Avantium NV with three other
miscellaneous service companies in Europe:
Tissue Regenix Group PLC
of UNITED KINGDOM
sales of £13.03 million [US$16.56 million]
of which 52%
Evolva Holding SA
(11.60 million Swiss Francs [US$12.54 million]
of which 100%
was Novel Food Nutritional & Pharmaceutical), and
based in FRANCE
(13.37 million Euros [US$15.55 million]
During the year ended December of 2019, sales at
Avantium NV were 13.82 million Euro (US$16.07 million).
increase of 22.5%
versus 2018, when the company's sales were 11.28 million Euro.
Sales of Renewable Chemistries saw an increase
that was more than double the company's growth rate: sales were up
191.5% in 2019, from
410,000.00 Euro to 1.20 million Euro.